22ème Congrès international sur le SIDA

Le 22ème Congrès international sur le SIDA (AIDS 2018) va avoir lieu à Amsterdam, aux Pays-Bas, du 23 au 27 juillet 2018.

NAM est ravi d’avoir été choisi par l’International AIDS Society comme partenaire médiatique scientifique officiel pour ce congrè.

Nous couvrirons les recherches les plus importantes présentées pendant le congrès, nous publierons les nouvelles en ligne sur www.aidsmap.com/aids2018 et nous enverrons par email des bulletins de synthèse sur le congrès : quatre bulletins électroniques pendant la conférence et un bulletin la semaine suivante.

Bulletins

Inscrivez-vous pour nos bulletins électroniques gratuits

NAM's news coverage of the 22nd International AIDS Conference has been supported by Gilead Sciences Europe Ltd. and ViiV Healthcare.



Official conference partners

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.